Cargando…
DNA methylation signatures of breast cancer in peripheral T-cells
BACKGROUND: Immune surveillance acts as a defense mechanism in cancer, and its disruption is involved in cancer progression. DNA methylation reflects the phenotypic identity of cells and recent data suggested that DNA methylation profiles of T cells and peripheral blood mononuclear cells (PBMC) are...
Autores principales: | Parashar, Surabhi, Cheishvili, David, Mahmood, Niaz, Arakelian, Ani, Tanvir, Imrana, Khan, Haseeb Ahmed, Kremer, Richard, Mihalcioiu, Catalin, Szyf, Moshe, Rabbani, Shafaat A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960123/ https://www.ncbi.nlm.nih.gov/pubmed/29776342 http://dx.doi.org/10.1186/s12885-018-4482-7 |
Ejemplares similares
-
Methyl donor S-adenosylmethionine (SAM) supplementation attenuates breast cancer growth, invasion, and metastasis in vivo; therapeutic and chemopreventive applications
por: Mahmood, Niaz, et al.
Publicado: (2017) -
S-adenosylmethionine blocks osteosarcoma cells proliferation and invasion in vitro and tumor metastasis in vivo: therapeutic and diagnostic clinical applications
por: Parashar, Surabhi, et al.
Publicado: (2015) -
DNA methylation signatures of Prostate Cancer in peripheral T-cells
por: Mehdi, Ali, et al.
Publicado: (2020) -
S‐adenosylmethionine in combination with decitabine shows enhanced anti‐cancer effects in repressing breast cancer growth and metastasis
por: Mahmood, Niaz, et al.
Publicado: (2020) -
A common promoter hypomethylation signature in invasive breast, liver and prostate cancer cell lines reveals novel targets involved in cancer invasiveness
por: Cheishvili, David, et al.
Publicado: (2015)